iShares Nasdaq Biotechnology ETF (IBB)
IBB is a passive ETF by iShares tracking the investment results of the NASDAQ Biotechnology Index. IBB launched on Feb 5, 2001 and has a 0.47% expense ratio.
ETF Info
US4642875565
464287556
Feb 5, 2001
North America (U.S.)
1x
NASDAQ Biotechnology Index
Multi-Cap
Growth
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in iShares Nasdaq Biotechnology ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
iShares Nasdaq Biotechnology ETF had a return of -1.65% year-to-date (YTD) and 13.24% in the last 12 months. Over the past 10 years, iShares Nasdaq Biotechnology ETF had an annualized return of 3.36%, while the S&P 500 had an annualized return of 11.16%, indicating that iShares Nasdaq Biotechnology ETF did not perform as well as the benchmark.
IBB
-1.65%
-8.64%
-2.35%
13.24%
3.56%
3.36%
^GSPC (Benchmark)
23.62%
0.54%
11.19%
30.63%
13.61%
11.16%
Monthly Returns
The table below presents the monthly returns of IBB, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -1.08% | 1.83% | 0.37% | -7.51% | 5.48% | 2.52% | 7.80% | 0.14% | -1.60% | -3.65% | -1.65% | ||
| 2023 | 4.01% | -6.86% | 1.61% | 1.05% | -3.24% | 0.54% | 1.85% | -0.46% | -4.87% | -7.04% | 6.38% | 12.44% | 3.76% |
| 2022 | -13.60% | -4.39% | 3.45% | -10.48% | 0.02% | 0.85% | 5.48% | -2.11% | -3.57% | 9.94% | 6.17% | -3.77% | -13.69% |
| 2021 | 6.04% | -2.31% | -3.97% | 2.71% | -1.74% | 7.72% | 1.30% | 3.92% | -6.09% | -1.29% | -3.37% | -1.01% | 0.95% |
| 2020 | -5.56% | 0.06% | -5.34% | 15.09% | 8.66% | 1.55% | -1.70% | 0.92% | -0.09% | -3.54% | 10.99% | 4.54% | 26.01% |
| 2019 | 13.75% | 2.78% | -0.83% | -4.81% | -6.05% | 9.21% | -3.15% | -2.58% | -3.27% | 7.88% | 11.47% | 0.77% | 25.21% |
| 2018 | 6.85% | -5.26% | -1.24% | -2.89% | 4.63% | 1.41% | 6.07% | 4.89% | -0.18% | -14.65% | 4.83% | -11.61% | -9.53% |
| 2017 | 4.78% | 6.89% | -1.23% | 1.49% | -3.99% | 8.57% | 2.91% | 4.47% | 0.11% | -5.82% | 0.50% | 1.56% | 21.08% |
| 2016 | -21.07% | -4.85% | 2.70% | 2.74% | 4.41% | -7.96% | 12.47% | -2.95% | 3.08% | -11.32% | 6.77% | -3.14% | -21.42% |
| 2015 | 6.03% | 4.92% | 1.77% | -2.84% | 9.40% | 1.09% | 3.68% | -10.60% | -11.30% | 7.30% | 2.74% | 1.19% | 11.56% |
| 2014 | 8.30% | 7.53% | -10.60% | -2.60% | 4.06% | 7.44% | -2.41% | 10.25% | -1.04% | 8.40% | 2.45% | -0.18% | 33.83% |
| 2013 | 6.09% | 1.52% | 8.21% | 7.74% | 4.17% | -3.09% | 13.77% | -2.07% | 8.19% | -2.04% | 9.17% | 1.29% | 65.54% |
Expense Ratio
IBB features an expense ratio of 0.47%, falling within the medium range.
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of IBB is 25, indicating that it is in the bottom 25% of ETFs on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for iShares Nasdaq Biotechnology ETF (IBB) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
iShares Nasdaq Biotechnology ETF provided a 0.34% dividend yield over the last twelve months, with an annual payout of $0.45 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.45 | $0.35 | $0.41 | $0.32 | $0.31 | $0.21 | $0.19 | $0.32 | $0.16 | $0.03 | $0.15 | $0.02 |
Dividend yield | 0.34% | 0.26% | 0.31% | 0.21% | 0.20% | 0.17% | 0.19% | 0.30% | 0.19% | 0.03% | 0.15% | 0.03% |
Monthly Dividends
The table displays the monthly dividend distributions for iShares Nasdaq Biotechnology ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.00 | $0.13 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.20 | $0.00 | $0.00 | $0.33 | |
| 2023 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.01 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.12 | $0.35 |
| 2022 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.10 | $0.41 |
| 2021 | $0.00 | $0.00 | $0.13 | $0.00 | $0.00 | $0.02 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.04 | $0.32 |
| 2020 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.13 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.07 | $0.31 |
| 2019 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.06 | $0.21 |
| 2018 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.00 | $0.19 |
| 2017 | $0.00 | $0.00 | $0.10 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.13 | $0.32 |
| 2016 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.03 | $0.16 |
| 2015 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.02 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 | $0.03 |
| 2014 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.13 | $0.00 | $0.00 | $0.02 | $0.00 | $0.00 | $0.00 | $0.15 |
| 2013 | $0.02 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.02 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the iShares Nasdaq Biotechnology ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the iShares Nasdaq Biotechnology ETF was 62.85%, occurring on Jul 10, 2002. Recovery took 2216 trading sessions.
The current iShares Nasdaq Biotechnology ETF drawdown is 23.64%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -62.85% | Jun 6, 2001 | 272 | Jul 10, 2002 | 2216 | Apr 27, 2011 | 2488 |
| -39.82% | Aug 10, 2021 | 216 | Jun 16, 2022 | — | — | — |
| -39.24% | Jul 21, 2015 | 237 | Jun 27, 2016 | 974 | May 11, 2020 | 1211 |
| -34.69% | Feb 13, 2001 | 35 | Apr 3, 2001 | 34 | May 22, 2001 | 69 |
| -22.66% | Jul 11, 2011 | 21 | Aug 8, 2011 | 107 | Jan 10, 2012 | 128 |
Volatility
Volatility Chart
The current iShares Nasdaq Biotechnology ETF volatility is 7.06%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.